ArriVent BioPharma, Inc. AVBP Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by ArriVent BioPharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about ArriVent BioPharma, Inc.'s increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ArriVent BioPharma, Inc.'s increase (decrease) in prepaid expense and other assets?
- ArriVent BioPharma, Inc. (AVBP) reported increase (decrease) in prepaid expense and other assets of $2.56M in Q1 2026.
- How has ArriVent BioPharma, Inc.'s increase (decrease) in prepaid expense and other assets changed year-over-year?
- ArriVent BioPharma, Inc.'s increase (decrease) in prepaid expense and other assets increased by 61.0% year-over-year, from $1.59M to $2.56M.
- What is the long-term trend for ArriVent BioPharma, Inc.'s increase (decrease) in prepaid expense and other assets?
- Over 2 years (2023 to 2025), ArriVent BioPharma, Inc.'s increase (decrease) in prepaid expense and other assets has grown at a 15.2% compound annual growth rate (CAGR), from -$9.67M to $12.84M.
- What does increase (decrease) in prepaid expense and other assets mean?
- This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.